We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Has Strong Copaxone Sales; Par Posts Fourth-Quarter Loss
Teva Has Strong Copaxone Sales; Par Posts Fourth-Quarter Loss
March 7, 2006
Teva Pharmaceutical’s multiple sclerosis drug Copaxone achieved $1.18 billion in sales in 2005, making it Teva’s first blockbuster drug, according to the firm best known as a generic drug powerhouse.